Both Non-Avian, Different Tiers
Genvisc 850 and Durolane share one important trait: both are made through bacterial fermentation, making them safe for patients with bird or egg allergies. Beyond that, they occupy different tiers of the HA market. Genvisc 850 is the affordable multi-injection option. Durolane is a premium single-injection product using patented NASHA (Non-Animal Stabilized Hyaluronic Acid) technology.
Side-by-Side Comparison
| Factor | Genvisc 850 | Durolane |
|---|---|---|
| Injections | 3 or 5 weekly | 1 (single) |
| Source | Bacterial fermentation | Bacterial fermentation (NASHA) |
| Bird allergy safe | Yes | Yes |
| Molecular weight | 500-730 kDa | Very high (cross-linked) |
| Volume | 2.5 mL per injection | 3 mL (once) |
| J-Code | J7320 | J7318 |
| Self-pay cost | $400-$700 | $800-$1,300 |
| Medicare | Yes | Yes |
Genvisc 850: Affordable Non-Avian HA
Advantages
Considerations
Durolane: Premium NASHA Technology
Advantages
Considerations
NASHA Technology Explained
Durolane’s NASHA process stabilizes hyaluronic acid molecules through minimal cross-linking, creating a gel that resists breakdown by enzymes in the joint. This engineering means the HA stays in the knee longer than standard formulations. The process uses no animal products and produces a highly purified gel with consistent properties.
Standard HA like Genvisc 850 is not cross-linked and gets metabolized by the body more quickly. While both relieve pain, cross-linked products may maintain their effect longer in some patients.
Making Your Decision
Choose Genvisc 850 if:
- Cost savings are your priority
- You can manage 3-5 weekly visits
- You want the most affordable non-avian option
- You’re trying HA therapy for the first time at low financial risk
Choose Durolane if:
- Single-visit convenience matters
- You want advanced cross-linked HA technology
- You need a non-avian product but want premium quality
- Budget is less of a concern
Frequently Asked Questions
Is Durolane really worth double the price?
For patients who struggle to attend multiple appointments, the convenience may justify the premium. Durolane also offers cross-linked technology that standard HA does not. However, if cost matters, Genvisc 850 treats the same condition effectively at half the price.
Both are non-avian. Are they the same?
No. Both use bacterial fermentation as the HA source, but Durolane undergoes additional NASHA cross-linking that changes the gel’s properties. Genvisc 850 is standard non-cross-linked HA.
Which lasts longer in the knee?
Durolane’s cross-linking is designed to resist breakdown, which may extend its duration. Clinical studies show both provide approximately 6 months of relief, though some patients report longer duration with Durolane.
Can my doctor help me decide?
Absolutely. Your doctor can consider your arthritis severity, activity level, insurance coverage, and personal preferences. If both are covered equally by your plan, the choice often comes down to convenience vs. cost.
The Bottom Line
Genvisc 850 delivers non-avian HA therapy at the lowest price on the market.
Durolane delivers non-avian HA therapy with the most advanced single-injection technology.
For allergy patients, these are your two best options. Your budget and schedule determine which tier makes sense.
Find HA Injection Providers
Connect with specialists offering non-avian gel injections.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderTreatment Updates
Stay informed about viscosupplementation options and costs.
Join 10,000+ readers. No spam.